EPW
BSX icon

Evolve Private Wealth’s Boston Scientific BSX Stock Holding History

Evolve Private Wealth’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$589K Buy
13,789
+5,257
+62% +$285K 0.04% 451
2026
Q1 		$535K Buy
8,532
+5,410
+173% +$433K 0.03% 547
2025
Q4 		$298K Buy
+3,122
New +$306K 0.02% 723

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Evolve Private Wealth's BSX Position: Q2 2026 in Review

Evolve Private Wealth increased its Boston Scientific (BSX) stake by 62% in Q2 2026, buying an estimated $285K and bringing the position to 13,789 shares worth $589K. The position accounts for 0.04% of the portfolio, ranked #451.

Evolve Private Wealth first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Evolve Private Wealth held 13,789 shares of Boston Scientific worth $589K as of Q2 2026.
  • Evolve Private Wealth bought 5,257 Boston Scientific shares in Q2 2026, an estimated $285K.
  • Boston Scientific made up 0.04% of Evolve Private Wealth's portfolio in Q2 2026, its #451 holding.
  • Evolve Private Wealth first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Evolve Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.